These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 2170136)
1. Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro. Snoeck R; Lagneaux L; Delforge A; Bron D; Van der Auwera P; Stryckmans P; Balzarini J; De Clercq E Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):615-9. PubMed ID: 2170136 [TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique. Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725 [TBL] [Abstract][Full Text] [Related]
3. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro. Shigeta S; Konno K; Baba M; Yokota T; De Clercq E J Infect Dis; 1991 Feb; 163(2):270-5. PubMed ID: 1846389 [TBL] [Abstract][Full Text] [Related]
4. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro. Snoeck R; Andrei G; De Clercq E Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075 [TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG). Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213 [TBL] [Abstract][Full Text] [Related]
6. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication. Snoeck R; Sakuma T; De Clercq E; Rosenberg I; Holy A Antimicrob Agents Chemother; 1988 Dec; 32(12):1839-44. PubMed ID: 2854454 [TBL] [Abstract][Full Text] [Related]
7. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus. Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517 [TBL] [Abstract][Full Text] [Related]
8. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro. Neyts J; Snoeck R; Balzarini J; De Clercq E Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729 [TBL] [Abstract][Full Text] [Related]
9. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity. Neyts J; De Clercq E Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749 [TBL] [Abstract][Full Text] [Related]
10. Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs. Li SB; Yang ZH; Feng JS; Fong CK; Lucia HL; Hsiung GD Antiviral Res; 1990 May; 13(5):237-52. PubMed ID: 2168690 [TBL] [Abstract][Full Text] [Related]
11. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates. Aduma P; Connelly MC; Srinivas RV; Fridland A Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743 [TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of acyclic nucleoside phosphonate analogs, including (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, on Epstein-Barr virus replication. Lin JC; De Clercq E; Pagano JS Antimicrob Agents Chemother; 1991 Nov; 35(11):2440-3. PubMed ID: 1666500 [TBL] [Abstract][Full Text] [Related]
14. Antiviral drug susceptibility of human herpesvirus 8. Neyts J; De Clercq E Antimicrob Agents Chemother; 1997 Dec; 41(12):2754-6. PubMed ID: 9420052 [TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates. Smeijsters LJ; Franssen FF; Naesens L; de Vries E; Holý A; Balzarini J; de Clercq E; Overdulve JP Int J Antimicrob Agents; 1999 Jun; 12(1):53-61. PubMed ID: 10389648 [TBL] [Abstract][Full Text] [Related]
17. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7]. Takahashi K Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679 [TBL] [Abstract][Full Text] [Related]
18. Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method. Kodama E; Shigeta S; Suzuki T; De Clercq E Antiviral Res; 1996 Jul; 31(3):159-64. PubMed ID: 8811200 [TBL] [Abstract][Full Text] [Related]
19. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo. Stals FS; de Clercq E; Bruggeman CA Antimicrob Agents Chemother; 1991 Nov; 35(11):2262-6. PubMed ID: 1666493 [TBL] [Abstract][Full Text] [Related]
20. Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro. van der Strate BW; De Boer FM; Bakker HI; Meijer DK; Molema G; Harmsen MC Antiviral Res; 2003 Apr; 58(2):159-65. PubMed ID: 12742576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]